高级检索
当前位置: 首页 > 详情页

A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDY COMPARING EFFICACY OF DOTINURAD AND FEBUXOSTAT FOR THE TREATMENT OF GOUT IN CHINESE SUBJECTS

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP) ◇ 自然指数

机构: [1]Peking Univ First Hosp, Dept Rheumatol, Beijing, Peoples R China [2]Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Peoples R China [3]Beijing Hosp, Dept Rheumatol, Beijing, Peoples R China [4]Foshan First Peoples Hosp, Dept Rheumatol, Foshan, Peoples R China [5]Jiangxi Pingxiang Peoples Hosp, Dept Rheumatol, Pingxiang, Peoples R China [6]Shenzhen Peoples Hosp, Dept Rheumatol, Shenzhen, Peoples R China [7]Dalian Med Univ, Dalian Municipal Cent Hosp Affiliated, Dept Endocrinol, Dalian, Peoples R China [8]Qingdao Univ, Affiliated Hosp, Dept Metab Dis, Qingdao, Peoples R China [9]Nanjing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Nanjing, Peoples R China [10]Dalian Med Univ, Affiliated Hosp 2, Dept Rheumatol, Dalian, Peoples R China [11]Shanghai Jiao Tong Univ, Tong Ren Hosp, Sch Med, Dept Rheumatol & Immunol, Shanghai, Peoples R China [12]First Hosp Jilin Univ, Dept Rheumatol, Jilin, Peoples R China [13]Cent South Univ, Xiangya Hosp 3, Dept Nephrol & Rheumatol, Changsha, Peoples R China [14]Dalian Med Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Dalian, Peoples R China [15]Jieyang Peoples Hosp, Dept Rheumatol, Jieyang, Peoples R China [16]Eisai China Inc, Beijing, Peoples R China [17]Eisai & Co Ltd, Tokyo, Japan
出处:
ISSN:

关键词: Clinical Trial Randomized controlled trial

语种:
WOS:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 风湿病学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 风湿病学
JCR分区:
出版当年[2022]版:
Q1 RHEUMATOLOGY
最新[2024]版:
Q1 RHEUMATOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [2]Southern Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:29032 今日访问量:0 总访问量:1619 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)